Madeleine Hanekom

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

A. Diacon, M. Hoelscher, K. Reither, 2017, The Lancet. Infectious diseases.